These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
191 related articles for article (PubMed ID: 11911289)
1. Prognostic significance of Ape1/ref-1 subcellular localization in non-small cell lung carcinomas. Puglisi F; Aprile G; Minisini AM; Barbone F; Cataldi P; Tell G; Kelley MR; Damante G; Beltrami CA; Di Loreto C Anticancer Res; 2001; 21(6A):4041-9. PubMed ID: 11911289 [TBL] [Abstract][Full Text] [Related]
2. Prognostic role of Ape/Ref-1 subcellular expression in stage I-III breast carcinomas. Puglisi F; Barbone F; Tell G; Aprile G; Pertoldi B; Raiti C; Kelley MR; Damante G; Sobrero A; Beltrami CA; Di Loreto C Oncol Rep; 2002; 9(1):11-7. PubMed ID: 11748448 [TBL] [Abstract][Full Text] [Related]
3. Nuclear localization of human AP endonuclease 1 (HAP1/Ref-1) associates with prognosis in early operable non-small cell lung cancer (NSCLC). Kakolyris S; Giatromanolaki A; Koukourakis M; Kaklamanis L; Kanavaros P; Hickson ID; Barzilay G; Georgoulias V; Gatter KC; Harris AL J Pathol; 1999 Nov; 189(3):351-7. PubMed ID: 10547596 [TBL] [Abstract][Full Text] [Related]
4. Alteration of APE1/ref-1 expression in non-small cell lung cancer: the implications of impaired extracellular superoxide dismutase and catalase antioxidant systems. Yoo DG; Song YJ; Cho EJ; Lee SK; Park JB; Yu JH; Lim SP; Kim JM; Jeon BH Lung Cancer; 2008 May; 60(2):277-84. PubMed ID: 18061304 [TBL] [Abstract][Full Text] [Related]
5. Subcellular localization of apurinic endonuclease 1 promotes lung tumor aggressiveness via NF-kappaB activation. Wu HH; Cheng YW; Chang JT; Wu TC; Liu WS; Chen CY; Lee H Oncogene; 2010 Jul; 29(30):4330-40. PubMed ID: 20498636 [TBL] [Abstract][Full Text] [Related]
6. Elevated and altered expression of the multifunctional DNA base excision repair and redox enzyme Ape1/ref-1 in prostate cancer. Kelley MR; Cheng L; Foster R; Tritt R; Jiang J; Broshears J; Koch M Clin Cancer Res; 2001 Apr; 7(4):824-30. PubMed ID: 11309329 [TBL] [Abstract][Full Text] [Related]
7. Cytoplasmic Ape1 expression elevated by p53 aberration may predict survival and relapse in resected non-small cell lung cancer. Wu HH; Chu YC; Wang L; Tsai LH; Lee MC; Chen CY; Shieh SH; Cheng YW; Lee H Ann Surg Oncol; 2013 Dec; 20 Suppl 3():S336-47. PubMed ID: 22688662 [TBL] [Abstract][Full Text] [Related]
8. Thioredoxin expression is associated with lymph node status and prognosis in early operable non-small cell lung cancer. Kakolyris S; Giatromanolaki A; Koukourakis M; Powis G; Souglakos J; Sivridis E; Georgoulias V; Gatter KC; Harris AL Clin Cancer Res; 2001 Oct; 7(10):3087-91. PubMed ID: 11595699 [TBL] [Abstract][Full Text] [Related]
9. Altered expression of Ape1/ref-1 in germ cell tumors and overexpression in NT2 cells confers resistance to bleomycin and radiation. Robertson KA; Bullock HA; Xu Y; Tritt R; Zimmerman E; Ulbright TM; Foster RS; Einhorn LH; Kelley MR Cancer Res; 2001 Mar; 61(5):2220-5. PubMed ID: 11280790 [TBL] [Abstract][Full Text] [Related]
10. [Correlation of P27 expression and localization to phosphorylated AKT in non-small cell lung cancer]. Miao LJ; Wang J; Li SS; Wu YM; Wu YJ; Wang XC Ai Zheng; 2006 Oct; 25(10):1216-20. PubMed ID: 17059763 [TBL] [Abstract][Full Text] [Related]
11. APE1 overexpression is associated with cisplatin resistance in non-small cell lung cancer and targeted inhibition of APE1 enhances the activity of cisplatin in A549 cells. Wang D; Xiang DB; Yang XQ; Chen LS; Li MX; Zhong ZY; Zhang YS Lung Cancer; 2009 Dec; 66(3):298-304. PubMed ID: 19324449 [TBL] [Abstract][Full Text] [Related]
12. Apurinic apyrimidinic endonuclease/redox effector factor 1 immunoreactivity and grading in hepatocellular carcinoma risk of relapse after liver transplantation. Avellini C; Orsaria M; Baccarani U; Adani GL; Lorenzin D; Bresadola V; Bresadola F; Beltrami CA Transplant Proc; 2010 May; 42(4):1204-8. PubMed ID: 20534262 [TBL] [Abstract][Full Text] [Related]
13. Upregulation of APE/ref-1 in recurrence stage I, non small cell lung cancer. Kang MW; Kang SK; Choi S; Lee CS; Jeon BH; Lim SP Asian Cardiovasc Thorac Ann; 2012 Feb; 20(1):36-41. PubMed ID: 22371940 [TBL] [Abstract][Full Text] [Related]
14. Nuclear and cytoplasmic cellular distribution of survivin as survival predictor in resected non-small-cell lung cancer. Bria E; Visca P; Novelli F; Casini B; Diodoro MG; Perrone-Donnorso R; Botti C; Sperduti I; Facciolo F; Milella M; Cecere FL; Cognetti F; Mottolese M Eur J Surg Oncol; 2008 May; 34(5):593-8. PubMed ID: 17693049 [TBL] [Abstract][Full Text] [Related]
15. Alterations in the expression of the apurinic/apyrimidinic endonuclease-1/redox factor-1 (APE1/Ref-1) in human ovarian cancer and indentification of the therapeutic potential of APE1/Ref-1 inhibitor. Zhang Y; Wang J; Xiang D; Wang D; Xin X Int J Oncol; 2009 Nov; 35(5):1069-79. PubMed ID: 19787261 [TBL] [Abstract][Full Text] [Related]
16. Prognostic significance of human apurinic/apyrimidinic endonuclease (APE/Ref-1) expression in rectal cancer treated with preoperative radiochemotherapy. Kim JS; Kim JM; Liang ZL; Jang JY; Kim S; Huh GJ; Kim KH; Cho MJ Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):130-7. PubMed ID: 21075552 [TBL] [Abstract][Full Text] [Related]
17. Correlation between survivin expression and prognosis in non-small cell lung cancer. Atikcan S; Unsal E; Demirag F; Köksal D; Yilmaz A Respir Med; 2006 Dec; 100(12):2220-6. PubMed ID: 16650973 [TBL] [Abstract][Full Text] [Related]
18. Prognostic implications of cell cycle-related proteins in primary resectable pathologic N2 nonsmall cell lung cancer. Mohamed S; Yasufuku K; Hiroshima K; Nakajima T; Yoshida S; Suzuki M; Sekine Y; Shibuya K; Iizasa T; Farouk A; Fujisawa T Cancer; 2007 Jun; 109(12):2506-14. PubMed ID: 17487846 [TBL] [Abstract][Full Text] [Related]